Creative Planning
ABMD

Creative Planning’s Abiomed Inc ABMD Stock Holding History

Creative Planning’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-300
Closed -$1K – 2143
2019
Q4 		$1K Sell
300
-300
-50% -$55.6K ﹤0.01% 1992
2019
Q3 		$5K Hold
600
– – ﹤0.01% 1925
2019
Q2 		$22K Hold
600
– – ﹤0.01% 1884
2019
Q1 		$34K Hold
600
– – ﹤0.01% 1808
2018
Q4 		$57K Buy
+600
New +$208K ﹤0.01% 1697

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Creative Planning's ABMD Position: Q4 2022 in Review

Creative Planning sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 8,243 shares — an estimated $2.02M sold.

Creative Planning first reported a position in ABMD in Q3 2013 and held it in 32 quarters. The position peaked at $4.76M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Creative Planning reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Creative Planning sold 8,243 Abiomed Inc shares in Q4 2022, an estimated $2.02M.
  • Creative Planning first reported a position in Abiomed Inc in Q3 2013 and held it in 32 quarters.
  • Creative Planning's Abiomed Inc position peaked at $4.76M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Creative Planning's 13F filing for Q4 2022, filed 10 Feb 2023.